Lysine-specific Demethylase 1 and Salt-sensitivity in Humans
1 other identifier
interventional
88
1 country
1
Brief Summary
The purpose of this study is to investigate the role dietary salt plays in epigenetic regulation of blood pressure, focusing on the salt-sensitive regulatory enzyme Lysine-specific demethylase 1.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 2, 2017
CompletedFirst Submitted
Initial submission to the registry
January 20, 2017
CompletedFirst Posted
Study publicly available on registry
January 24, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 2, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
ExpectedNovember 21, 2025
November 1, 2025
5 years
January 20, 2017
November 18, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Aldosterone response to angiotensin II
Change in aldosterone, baseline to after angiotensin II by genotype/race
After 1 week dietary salt manipulation
Secondary Outcomes (2)
Renal blood flow response to dietary salt
After 1 week dietary salt manipulation on both diets
Vascular stiffness response to angiotensin II
After 1 week dietary salt manipulation
Study Arms (4)
Afr-Amer risk allele
ACTIVE COMPARATORAfrican Americans carrying the LSD1 affected allele
Cauc risk allele
PLACEBO COMPARATORCaucasians carrying the LSD1 affected allele
Afr-Amer non-risk allele
PLACEBO COMPARATORAfrican Americans carrying the LSD1 non-risk allele
Cauc non-risk allele
PLACEBO COMPARATORCaucasians carrying the LSD1 non-risk allele
Interventions
Change in aldosterone from baseline to after Ang II infusion on a LS diet
Change in renal blood flow: High salt to low salt diet
Change in vascular stiffness, baseline compared to AngII
Eligibility Criteria
You may qualify if:
- Age 25-45 years
- Caucasian or African American
- No gender preference (anticipate 50% female)
- Normotensive (screening blood pressure \<140/90 mmHg)
- No history of hypertension, diabetes, stroke, coronary artery disease, kidney disease, cancer, thyroid disease, preeclampsia, or hospitalizations in 6 months
- Normal screening laboratory values (CMP, TSH, A1c)
- Normal ECG
- BMI \<25 kg/m2
You may not qualify if:
- Pregnancy
- Breast feeding
- Any medication or herbal preparation
- \>6oz alcohol/week
- Tobacco use
- Illicit drug use
- Chronic NSAID use
- Recent steroid use (injected, inhaled, oral)
- Decongestant use in the past 2 weeks
- Known sensitivity to infused Angiotensin II or para-amino hippurate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Related Publications (4)
Krug AW, Tille E, Sun B, Pojoga L, Williams J, Chamarthi B, Lichtman AH, Hopkins PN, Adler GK, Williams GH. Lysine-specific demethylase-1 modifies the age effect on blood pressure sensitivity to dietary salt intake. Age (Dordr). 2013 Oct;35(5):1809-20. doi: 10.1007/s11357-012-9480-0. Epub 2012 Oct 2.
PMID: 23054827BACKGROUNDWilliams JS, Chamarthi B, Goodarzi MO, Pojoga LH, Sun B, Garza AE, Raby BA, Adler GK, Hopkins PN, Brown NJ, Jeunemaitre X, Ferri C, Fang R, Leonor T, Cui J, Guo X, Taylor KD, Ida Chen YD, Xiang A, Raffel LJ, Buchanan TA, Rotter JI, Williams GH, Shi Y. Lysine-specific demethylase 1: an epigenetic regulator of salt-sensitive hypertension. Am J Hypertens. 2012 Jul;25(7):812-7. doi: 10.1038/ajh.2012.43. Epub 2012 Apr 26.
PMID: 22534796BACKGROUNDPojoga LH, Williams JS, Yao TM, Kumar A, Raffetto JD, do Nascimento GR, Reslan OM, Adler GK, Williams GH, Shi Y, Khalil RA. Histone demethylase LSD1 deficiency during high-salt diet is associated with enhanced vascular contraction, altered NO-cGMP relaxation pathway, and hypertension. Am J Physiol Heart Circ Physiol. 2011 Nov;301(5):H1862-71. doi: 10.1152/ajpheart.00513.2011. Epub 2011 Aug 26.
PMID: 21873498BACKGROUNDHeydarpour M, Parksook WW, Pojoga LH, Williams GH, Williams JS. Mineralocorticoid Receptor and Aldosterone: Interaction Between NR3C2 Genetic Variants, Sex, and Age in a Mixed Cohort. J Clin Endocrinol Metab. 2024 Dec 18;110(1):e140-e149. doi: 10.1210/clinem/dgae127.
PMID: 38437868DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Physician, Brigham and Women's Hospital
Study Record Dates
First Submitted
January 20, 2017
First Posted
January 24, 2017
Study Start
January 2, 2017
Primary Completion
January 2, 2022
Study Completion (Estimated)
June 1, 2026
Last Updated
November 21, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will share
IPD will be shared first thru the publication of research results in peer-review scientific journals by the study investigator. IPD will be made available upon reasonable request from bona fide research organizations in an effort to provide broader impact and enrich public health knowledge. Research volunteer PHI will not be shared, and all participant data will be de-identified and coded. Only encrypted and secure network exchanges will be used for data transfer. Cost sharing my be required in order prepare datasets.